2026年6月25日 / 美国东部时间凌晨5:00 / KFF健康新闻
参议员罗恩·怀登与14名民主党共同提案人计划于当日提出一项法案,为传统医疗保险的消费者自付费用设定上限,这再次引发了关于该项目为何不限制参保者支出的长期争论。
即便该法案的支持者也承认,今年通过法案的希望渺茫。但此次提案再次为民主党提供了契机,使其能在11月大选前凸显选民对医疗费用的不满情绪。
民调显示,美国人非常担忧医疗负担能力问题。最近的一项盖洛普民调发现,不到一半的美国人表示自己能持续负担得起医疗费用。
怀登的法案将聚焦于许多人眼中传统医疗保险中一个关键的钱包问题:参保者在自付费用方面没有任何上限。
“医疗保险领域的其他所有参与者——雇主保险、《平价医疗法案》覆盖的计划——都设有自付上限,”这位俄勒冈州民主党议员告诉KFF健康新闻,“没有任何合理的常识性理由能解释,作为旗舰医疗项目的医疗保险为何没有同样的保障。”
与此同时,反对设置上限的人士可能会抨击该法案对联邦预算造成的巨额成本。
怀登已经明确表明了立场,他补充道:“我预计参议院辩论时会出现这样的论调:民主党想要公平对待传统医疗保险的参保者,而共和党则想帮助亿万富翁。”
政策与政治博弈背后的动因
核心问题在于,参保者在扣除自付免赔额后,仍需承担20%的医疗保险费用。如果没有上限,像癌症或长期住院这类高额医疗费用,可能会让参保者支付数千美元的自付成本。
这种担忧促使约43%的传统医疗保险参保者购买额外的保险,通常称为“补充医疗保险(Medigap)”。另有部分参保者通过退休后在职福利计划获得此类保障。
补充医疗保险的保费近年来快速上涨,每年成本可达数千美元,对夫妻参保者而言尤为如此。部分参保者可能负担不起这笔费用,转而选择商业保险公司提供的私营医疗保险优势计划,或是干脆放弃额外保险。
怀登的提案将为传统医疗保险设定5000美元的自付费用上限。补充医疗保险计划或退休健康计划为参保者支付的任何费用都将计入该上限。提案还包含其他帮助低收入老年人的条款,包括取消申请成本减免特别项目的资产测试要求。
医疗保险将承担超过5000美元上限的部分费用,这一金额低于国会为竞争对手医疗保险优势计划设定的上限——目前为9250美元,不过保险公司可以设定更低的额度。
支持者认为,为传统医疗保险设置上限将有助于平衡传统医保与优势计划之间的竞争环境。优势计划的参保者自付费用通常远低于购买补充保险的传统医保参保者。他们表示,优势计划的保费可能会更低,因为保险公司的财务风险得到了限制。
医疗保险优势计划历来得到共和党人的大力支持,共和党人认可其私营部门属性,并指出该计划在控制成本方面可以发挥更多作用,例如使用特定的医生和医院网络,或是对部分服务要求预先审批,而传统医保无法做到这些。
这类计划还为参保者提供额外福利,如眼镜、助听器和处方药保险,目前已吸引了超过一半的医疗保险参保者。
但随着参保人数的增长,外界对该计划的审查也在增加,人们担忧其会拒绝患者服务,以及参保者若想转回传统医保会面临诸多困难。近期,一些医疗系统以付款延迟或预先审批要求为由退出了医疗保险优势计划合同,而保险公司也在缩减优势计划的覆盖范围。
国会预算办公室尚未对该法案进行分析,因此没有官方的纳税人医保成本增量估算。不过,该法案确实会增加联邦成本——而当前其他医疗项目正面临削减,医疗保险信托基金预计将在2033年开始出现资金缺口,美国国债也在不断增长。
这可能会招致财政鹰派和其他保守派的强烈批评,他们质疑是否应该动用数十亿美元的税收资金来承担原本应由参保者或其购买的补充保险计划支付的费用。他们可能会指出,参保者也可以选择加入私营的医疗保险优势计划,这样就无需购买补充医疗保险,如补充医疗保险。
核心问题:谁受益?谁买单?
尽管尚未进行官方成本核算,但设置自付上限可能会给纳税人带来重大成本,不过这也能为个别消费者节省开支。布朗大学最近的一项研究提供了一些线索。
该研究显示,5000美元的自付上限每年可为参保者平均节省约1200美元,包括直接节省的费用和补充医疗保险保费的降低。这项未接受外部资助的研究指出,如果该法案在2028年实施,略高于11%的传统医疗保险参保者(约320万人)将直接受益。
研究估计,在未来10年内,略高于52%的传统医保参保者至少会有一次自付费用超过5000美元的情况。
不过,该研究的主要作者、布朗大学公共卫生学院教授安德鲁·瑞安表示,分析人士估计,设置这样的上限“每年可能会给联邦财政增加超过500亿美元的支出,这是一笔巨款”。
批评者可能会聚焦于该上限的成本以及受益人群的数量。
“有多少参保者在医疗保险上遇到了自己负担不起的费用水平?”保守派智库帕拉贡健康研究所的高级政策分析师杰克逊·哈蒙德问道。该智库对共和党有较大影响力。
哈蒙德在法案推出前接受KFF健康新闻采访时表示,任何上限“通常都会增加医保项目的支出,却不会为参保者带来太多好处”。
但支持者持有不同观点。
“任何需要花钱的政策,都会围绕资金来源展开争论,”自由派智库美国进步中心的研究员布莱恩·凯泽说道,他也在怀登的法案推出前接受了KFF健康新闻的采访。
凯泽共同撰写了一份医疗保险相关论文,建议议员可以通过减少政府支付给医疗保险优势计划保险公司的费用,来为传统医保的改革(如设置自付上限)筹集资金。他指出,政府估计,今年医保优势计划的成本将比相同人数参保的传统医保高出760亿美元。
凯泽说,找到设立自付上限的资金来源“是正确且公平的,因为如果没有这项措施,患上重病的人可能会将毕生积蓄都花在医疗保险的自付费用上”。
不过,这类想法多年来一直在被反复讨论。法案的支持者也清楚这一点,他们承认法案通过的可能性不大,但表示目前他们正在为长期目标而努力。
“我们将在新一届国会推动这项法案,我们相信届时我们将占据多数席位,”怀登说道。
KFF健康新闻是一家专注医疗问题深度报道的全国性新闻编辑部,也是KFF的核心运营项目之一。KFF是独立的医疗政策研究、民调与新闻资讯来源机构。
Democrats to propose bill capping out-of-pocket Medicare costs for enrollees
June 25, 2026 / 5:00 AM EDT / KFF Health News
Sen. Ron Wyden and 14 Democratic co-sponsors plan to introduce legislation today to cap consumers’ potential out-of-pocket costs in traditional Medicare, resurfacing a long-running debate over why the program doesn’t limit beneficiary spending.
Even the bill’s backers say securing passage this year is a long shot. But the effort is one more opportunity for Democrats to highlight voters’ frustration about healthcare costs leading into the November election.
Polls show Americans are very concerned about affordability, with a recent Gallup survey finding fewer than half of Americans say they can consistently afford healthcare.
Wyden’s bill would focus on what many consider a critical pocketbook issue in traditional Medicare: There’s no limit on what a beneficiary could pay in cost sharing.
“Everyone else in the health insurance neighborhood has one — employer coverage, the Affordable Care Act, all of them have a cap,” the Oregon Democrat told KFF Health News. “There’s no good, common-sense reason why the flagship health program doesn’t have the same protection.”
Critics of a cap, meanwhile, are likely to pounce on the cost to the federal budget, which could be significant.
Wyden, already making the battle lines clear, added, “I suspect it will come up on the floor of the Senate that Democrats want to give a fair shake to people on traditional Medicare and Republicans want to help billionaires.”
Policy, political dynamics at work
The underlying issue is the 20% share of Medicare costs that enrollees have to pay for medical services after they’ve met any deductibles. Without a ceiling or upper limit, an expensive condition such as cancer or a long hospital stay could result in beneficiaries paying thousands of dollars in costs.
That concern leads about 43% of people enrolled in traditional Medicare to purchase separate insurance, often called Medigap. (Others get such coverage through job-based retiree plans.)
Medigap insurance plans have seen rapid premium increases and can cost thousands of dollars a year, especially for couples. That price tag can be unaffordable for some beneficiaries, who may instead turn to private-sector Medicare Advantage plans offered by commercial insurers, or go without.
The Wyden proposal would set a $5,000 cap in traditional Medicare. Any amounts paid by a Medigap plan or a retiree health plan toward beneficiaries’ care would count toward that cap. It also includes other provisions to help older people with lower incomes, including eliminating an asset test to qualify for special programs that help reduce costs.
Medicare would pick up any amounts over that $5,000 limit, which is lower than the one Congress set for the rival Advantage plans — currently $9,250, although insurers can set smaller amounts.
Setting a cap in the traditional program, proponents argue, would help level the playing field between traditional Medicare and Advantage plans, which often cost consumers far less than traditional Medicare with a Medigap supplement. Premiums for these policies would probably be lower, they say, because the insurers’ financial exposure would be limited.
The Medicare Advantage program has historically had strong support from Republicans, who like its private-sector aspect and note that it can potentially do more to control costs, such as by using specific networks of doctors and hospitals, or requiring preapproval for some services, which the traditional program cannot do.
The plans also offer enrollees additional benefits, such as eyeglasses, hearing aids, and prescription drug coverage, and have now attracted more than half of all Medicare enrollees.
Along with that growth, however, has also come increased scrutiny over concerns about denials of patient services and the challenges some consumers face if they want to switch back to the traditional program. Recently, some health systems have dropped out of Medicare Advantage contracts, citing concerns about tardy payments or prior authorization requirements, while insurers are also scaling back where they offer Advantage coverage.
The bill has not yet been analyzed by the Congressional Budget Office, so there is no official estimate of increased costs to taxpayers for Medicare. Still, it would raise those costs — at a time when other health programs are being cut, the Medicare trust fund is scheduled to start falling short of funding in 2033, and the nation’s debt is growing.
That is likely to draw sharp rebukes from fiscal hawks and other conservatives who question whether billions in tax dollars should be used to pick up costs that would otherwise be paid by enrollees or by the supplemental insurance plans many purchase to do so. They are likely to note that beneficiaries could also choose to join private sector Advantage plans, which eliminate the need for supplementary insurance coverage such as Medigap.
Key questions: Who benefits? Who pays?
A cap’s cost to taxpayers, while not officially scored yet, is likely to be significant, although adding one could also save individual consumers money. A recent study from Brown University gives some clues.
A $5,000 cap could save enrollees an average of about $1,200 a year, the study says, both in direct savings and reductions in their Medigap supplemental premiums. Just over 11% of traditional Medicare beneficiaries, about 3.2 million, would directly benefit from such a cap if it was implemented in 2028, said the study, which did not receive outside funding.
Over the next 10 years, it estimates, just over 52% of all traditional beneficiaries would exceed the $5,000 cap at least once.
Still, lead author Andrew Ryan, a professor at Brown’s School of Public Health, said analysts estimated such a cap “could cost over $50 billion annually, which is a lot of money” to add to the federal balance sheet.
Critics are likely to focus on the cap’s expense and the number of people who might benefit.
“How many people are hitting a level of cost they can’t afford on Medicare? “asked Jackson Hammond, a senior policy analyst with the Paragon Health Institute, a conservative think tank influential with the GOP.
Any cap “is generally going to increase expenses for the program without adding a lot of benefits to enrollees,” said Hammond, who spoke with KFF Health News before the legislation was introduced.
Supporters, though, have a different view.
Certainly, with “any policy that’s going to cost money, there will be an argument over where the money is coming from,” said Brian Keyser, a research associate at the liberal Center for American Progress who also spoke with KFF Health News before the Wyden measure was introduced.
Keyser co-authored a Medicare paper that suggested lawmakers could pay for changes in traditional Medicare, such as an out-of-pocket cap, if they reduced the amount the government pays Medicare Advantage insurers, pointing to government estimates that Advantage would cost the government $76 billion more this year than if the same number of people were in the traditional program.
Finding a way to add a cap “is right and fair because without it, people who become seriously ill can spend their life savings on cost-sharing Medicare,” Keyser said.
Such an idea, however, has been in discussion on and off for years. Knowing that, the bill’s backers acknowledge that passage is unlikely — but they say they’re playing the long game for now.
“We’re going to push for it in the next Congress, when we believe we will be in the majority,” Wyden said.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.
发表回复